Immunoglobulin Y protects intestinal epithelium and modulates gut microbiota
Microbiome Research Reports · 21.04.2026 · 5 (2)
DOI: 10.20517/mrr.2025.104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiome Research Reports, online erschienen am 21.04.2026. Verfasst von Shahna Fathima und 4 weiteren Autor:innen. Beteiligte Einrichtung: IGY Immune Technologies & Life Sciences, Airdrie T4A 2G8, Canada. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Aim
This study investigated the effects of Muno-IgY®, a multi-pathogen-specific immunoglobulin Y (IgY), on microbial growth, adhesion, fermentation activity, and immune signaling using a multi-tiered in vitro approach.
Methods
IgY activity was first evaluated in Caco-2 adhesion and invasion assays using adherent-invasive Escherichia coli (AIEC) at optimized concentrations, followed by assessment in a SHIME® in vitro gut model inoculated with human fecal microbiota enriched in Enterobacteriaceae. Microbial composition, fermentation markers, and metabolite production were analyzed, and downstream effects on epithelial barrier integrity and immune signaling were evaluated using a Caco-2/peripheral blood mononuclear cell (PBMC) co-culture model exposed to SHIME® effluents.
Results
Muno-IgY® significantly reduced AIEC adhesion/invasion from 39.76% in controls to 13.08% and 9.13% at 3 and 6 mg/mL, respectively (P < 0.05). In the SHIME® model, IgY significantly increased acetate and propionate production (P < 0.05), alongside a marked increase in ammonium concentration (P < 0.01). Microbial biomass increased modestly, while alpha- and beta-diversity indices were not significantly altered. The compositional shifts indicated enrichment of beneficial and mucin-associated taxa and reduction of opportunistic or pathogenic species in the Muno-IgY® group. In Caco-2/PBMC co-cultures, IgY-treated effluent decreased transepithelial electrical resistance (TEER) indicating reduced barrier integrity (P < 0.05) but significantly decreased pro-inflammatory cytokines Interferon-γ (IFN-γ) and Interleukin-22 (IL-22) (P < 0.05).
Conclusions
Muno-IgY® demonstrates the ability to inhibit pathogen adhesion and modulate microbial composition and immune responses in vitro. These findings support its potential as a non-antibiotic approach for microbiome-targeted interventions, although further validation in vivo is required.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- IGY Immune Technologies & Life Sciences, Airdrie T4A 2G8, Canada.
- Department of Dermatology, University Medical Center of the Johannes Gutenberg University, Mainz 55131, Germany.
- Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA.
Zitieren
APA
Fathima, S., Sarkar, T., Sharma, N., Kilgore, P. E., & Nguyen, H. H. (2026). Immunoglobulin Y protects intestinal epithelium and modulates gut microbiota. Microbiome Research Reports, 5(2). https://doi.org/10.20517/mrr.2025.104
Vancouver
Fathima S, Sarkar T, Sharma N, Kilgore PE, Nguyen HH. Immunoglobulin Y protects intestinal epithelium and modulates gut microbiota. Microbiome Research Reports. 2026;5(2). doi:10.20517/mrr.2025.104
BibTeX
@article{Fathima2026,
author = {Fathima, Shahna and Sarkar, Tina and Sharma, Navneet and Kilgore, Paul E and Nguyen, Huan H},
title = {Immunoglobulin Y protects intestinal epithelium and modulates gut microbiota},
journal = {Microbiome Research Reports},
year = {2026},
volume = {5},
number = {2},
doi = {10.20517/mrr.2025.104}
}
EUVIMED